Skip to Main Content

Author Details

Ramon Flick
1996
33
26
PMIDPaper TitleJournal TitlePublished Year
24441019A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.Scientific Reports2014
22958258Virus-like particle-based countermeasures against Rift Valley fever virus.Zoonoses and Public Health2012
22808531Mutational analysis of positively charged amino acid residues of Uukuniemi phlebovirus nucleocapsid protein.Virus Res2012
20655330Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles.Journal of Virological Methods2010
20698970Oligomerization of Uukuniemi virus nucleocapsid protein.Virol J2010
19932911A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge.Virology2010
20421731Rift Valley fever virus: an unrecognized emerging threat?Human Vaccines2010
19625394Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors.J Virol2009
19486321The αGal HyperAcute(®) Technology: enhancing immunogenicity of antiviral vaccines by exploiting the natural αGal-mediated zoonotic blockade.Zoonoses and Public Health2009
19682499Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.Antiviral Research2009
18225953A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells.PLoS Pathogens2008
17904180Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.Virology2008
18614193RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses.Virology2008
16477309Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus.PLoS Pathog2006
16630639Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis.Virology2006
16375710Crimean-Congo hemorrhagic fever virus.Current Molecular Medicine2005
15767442RNA polymerase I-driven minigenome system for Ebola viruses.Journal of Virology2005
15850490Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins.Virology Journal2005
15727815Reverse genetics of negative-stranded RNA viruses: a global perspective.FEMS Microbiology Letters2005
16375716Rift Valley fever virus.Current Molecular Medicine2005
15033561Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment.Virology2004
15479814Functional analysis of the noncoding regions of the Uukuniemi virus (Bunyaviridae) RNA segments.Journal of Virology2004
12642095Rescue of Hantaan virus minigenomes.Virology2003
12775768Mass spectrometric characterization of proteins from the SARS virus: a preliminary report.Molecular and Cellular Proteomics2003
12719591Reverse genetics for crimean-congo hemorrhagic fever virus.Journal of Virology2003
12730501The Genome sequence of the SARS-associated coronavirus.Science2003
12368328Mutational analysis of the Uukuniemi virus (Bunyaviridae family) promoter reveals two elements of functional importance.Journal of Virology2002
11160662Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs.Journal of Virology2001
11453070The packaging signal of influenza viral RNA molecules.RNA2001
11689061Functional analysis of the influenza A virus cRNA promoter and construction of an ambisense transcription system.Virology2001
10489344Transient bicistronic vRNA segments for indirect selection of recombinant influenza viruses.Virology1999
10573148Interaction of influenza virus polymerase with viral RNA in the 'corkscrew' conformation.Journal of General Virology1999
8849780Promoter elements in the influenza vRNA terminal structure.RNA1996
  • 1 - 33 of 33

Recommended Authors

Collaborators

University of Texas Medical Branch
Co-authored papers 4
Co-authored papers 2
Institute of Biotechnology, University of Helsinki
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Present address: Dxige Research Inc.
Co-authored papers 1
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Co-authored papers 1
Washington University
Co-authored papers 1
Co-authored papers 1
University of British Columbia
Co-authored papers 1
IBM Thomas J Watson Research Center, University of California Los Angeles, University of North Carolina at Chapel Hill
Co-authored papers 1
Co-authored papers 1
University of British Columbia
Co-authored papers 1
Co-authored papers 1
Carver College of Medicine, University of Iowa
Co-authored papers 1
Co-authored papers 1
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 1
Co-authored papers 1
BC Cancer Research Institute
Co-authored papers 1
University of Victoria
Co-authored papers 1
Brain Tumour Foundation of Canada
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Stanford University
Co-authored papers 1